Skip to content
Screener

Immunovant, Inc. IMVT United States — Effective tax rate

Similar metrics at other companies

EA
EAReportable Segment — Effective tax rate
$118M-22.9%
Mohawk Industries logo
MHKUnited States — Effective Income Tax Rate Reconciliation, Percent
5.3%-6.0pp
MTD
MTDREffective tax rate
$0.21-22.2%
MTD
MTDREffective tax rate
21%-6.0pp
Microvast Holdings, Inc. logo
MVSTGermany — Effective Tax Rate
7.3%0.0pp
Microvast Holdings, Inc. logo
MVSTPRC — Effective Tax Rate
3.8%0.0pp

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$8.21B+201%
Enterprise value$7.31B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0.0×
Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateContinuingOperations.

The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026.

Filed
May 20, 2026, 7:28 AM EDT
Fiscal year
FY2026
Accession
0001764013-26-000064

A reconciliation of the provision for income taxes computed at the U.S. federal statutory rate of 21% for the years ended March 31, 2025 and 2024 to the provision for income taxes reflected in the consolidated statements of operations is presented below (in thousands) in accordance with the guidance prior to the prospective adoption of ASU 2023-09. As such, certain items in the effective tax rate reconciliation above may have been reclassified between categories compared to prior periods; however, such reclassifications did not have a material impact on any individual line items or the overall effective tax rate.

Item 8. Financial Statements and Supplementary Data

FAQ

What is Immunovant, Inc.'s united states — effective tax rate?
Immunovant, Inc. (IMVT) reported united states — effective tax rate of 5.3% in Q1 2026.
How has Immunovant, Inc.'s united states — effective tax rate changed year-over-year?
Immunovant, Inc.'s united states — effective tax rate decreased by 0.0% year-over-year, from 5.3% to 5.3%.
What is the long-term trend for Immunovant, Inc.'s united states — effective tax rate?
Over 4 years (2022 to 2026), Immunovant, Inc.'s united states — effective tax rate has grown at a 0.0% compound annual growth rate (CAGR), from 21% to 21%.
What does united states — effective tax rate mean?
Calculated as the total income tax expense divided by the pre-tax income or loss for the United States segment. This ratio provides a standardized measure of the actual tax burden relative to domestic earnings, accounting for various tax credits and deductions. It is a critical metric for evaluating the company's tax management strategy.

Ask your AI about Immunovant, Inc.'s united states — effective tax rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude